2021 年 12 月至 2022 年 6 月,对无症状感染 SARS-CoV-2 Omicron 变异病毒的抗体反应。

IF 4.3 4区 医学 Q1 INFECTIOUS DISEASES Influenza and Other Respiratory Viruses Pub Date : 2024-07-16 DOI:10.1111/irv.13339
Ryan Sandford, Ruchi Yadav, Emma K. Noble, Kelsey Sumner, Devyani Joshi, Sara Y. Tartof, Karen J. Wernli, Emily T. Martin, Manjusha Gaglani, Richard K. Zimmerman, H. Keipp Talbot, Carlos G. Grijalva, Edward A. Belongia, Christina Carlson, Melissa Coughlin, Brendan Flannery, Brad Pearce, Eric Rogier
{"title":"2021 年 12 月至 2022 年 6 月,对无症状感染 SARS-CoV-2 Omicron 变异病毒的抗体反应。","authors":"Ryan Sandford,&nbsp;Ruchi Yadav,&nbsp;Emma K. Noble,&nbsp;Kelsey Sumner,&nbsp;Devyani Joshi,&nbsp;Sara Y. Tartof,&nbsp;Karen J. Wernli,&nbsp;Emily T. Martin,&nbsp;Manjusha Gaglani,&nbsp;Richard K. Zimmerman,&nbsp;H. Keipp Talbot,&nbsp;Carlos G. Grijalva,&nbsp;Edward A. Belongia,&nbsp;Christina Carlson,&nbsp;Melissa Coughlin,&nbsp;Brendan Flannery,&nbsp;Brad Pearce,&nbsp;Eric Rogier","doi":"10.1111/irv.13339","DOIUrl":null,"url":null,"abstract":"<p>We describe humoral immune responses in 105 ambulatory patients with laboratory-confirmed SARS-CoV-2 Omicron variant infection. In dried blood spot (DBS) collected within 5 days of illness onset and during convalescence, we measured binding antibody (bAb) against ancestral spike protein receptor binding domain (RBD) and nucleocapsid (N) protein using a commercial multiplex bead assay. Geometric mean bAb concentrations against RBD increased by a factor of 2.5 from 1258 to 3189 units/mL and by a factor of 47 against N protein from 5.5 to 259 units/mL between acute illness and convalescence; lower concentrations were associated with greater geometric mean ratios. Paired DBS specimens may be used to evaluate humoral response to SARS-CoV-2 infection.</p>","PeriodicalId":13544,"journal":{"name":"Influenza and Other Respiratory Viruses","volume":null,"pages":null},"PeriodicalIF":4.3000,"publicationDate":"2024-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/irv.13339","citationCount":"0","resultStr":"{\"title\":\"Antibody Response to Symptomatic Infection With SARS-CoV-2 Omicron Variant Viruses, December 2021–June 2022\",\"authors\":\"Ryan Sandford,&nbsp;Ruchi Yadav,&nbsp;Emma K. Noble,&nbsp;Kelsey Sumner,&nbsp;Devyani Joshi,&nbsp;Sara Y. Tartof,&nbsp;Karen J. Wernli,&nbsp;Emily T. Martin,&nbsp;Manjusha Gaglani,&nbsp;Richard K. Zimmerman,&nbsp;H. Keipp Talbot,&nbsp;Carlos G. Grijalva,&nbsp;Edward A. Belongia,&nbsp;Christina Carlson,&nbsp;Melissa Coughlin,&nbsp;Brendan Flannery,&nbsp;Brad Pearce,&nbsp;Eric Rogier\",\"doi\":\"10.1111/irv.13339\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>We describe humoral immune responses in 105 ambulatory patients with laboratory-confirmed SARS-CoV-2 Omicron variant infection. In dried blood spot (DBS) collected within 5 days of illness onset and during convalescence, we measured binding antibody (bAb) against ancestral spike protein receptor binding domain (RBD) and nucleocapsid (N) protein using a commercial multiplex bead assay. Geometric mean bAb concentrations against RBD increased by a factor of 2.5 from 1258 to 3189 units/mL and by a factor of 47 against N protein from 5.5 to 259 units/mL between acute illness and convalescence; lower concentrations were associated with greater geometric mean ratios. Paired DBS specimens may be used to evaluate humoral response to SARS-CoV-2 infection.</p>\",\"PeriodicalId\":13544,\"journal\":{\"name\":\"Influenza and Other Respiratory Viruses\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":4.3000,\"publicationDate\":\"2024-07-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1111/irv.13339\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Influenza and Other Respiratory Viruses\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/irv.13339\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Influenza and Other Respiratory Viruses","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/irv.13339","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

摘要

我们描述了 105 名经实验室确诊感染 SARS-CoV-2 Omicron 变体的非卧床患者的体液免疫反应。在发病后 5 天内和康复期间采集的干血斑(DBS)中,我们使用一种商用多聚酶珠测定法测定了针对祖先尖峰蛋白受体结合域(RBD)和核壳蛋白(N)的结合抗体(bAb)。在急性期和恢复期之间,针对 RBD 的几何平均 bAb 浓度增加了 2.5 倍,从 1258 个单位/毫升增至 3189 个单位/毫升;针对 N 蛋白的几何平均 bAb 浓度增加了 47 倍,从 5.5 个单位/毫升增至 259 个单位/毫升;浓度越低,几何平均比率越大。配对的 DBS 标本可用于评估对 SARS-CoV-2 感染的体液反应。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Antibody Response to Symptomatic Infection With SARS-CoV-2 Omicron Variant Viruses, December 2021–June 2022

We describe humoral immune responses in 105 ambulatory patients with laboratory-confirmed SARS-CoV-2 Omicron variant infection. In dried blood spot (DBS) collected within 5 days of illness onset and during convalescence, we measured binding antibody (bAb) against ancestral spike protein receptor binding domain (RBD) and nucleocapsid (N) protein using a commercial multiplex bead assay. Geometric mean bAb concentrations against RBD increased by a factor of 2.5 from 1258 to 3189 units/mL and by a factor of 47 against N protein from 5.5 to 259 units/mL between acute illness and convalescence; lower concentrations were associated with greater geometric mean ratios. Paired DBS specimens may be used to evaluate humoral response to SARS-CoV-2 infection.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
7.20
自引率
4.50%
发文量
120
审稿时长
6-12 weeks
期刊介绍: Influenza and Other Respiratory Viruses is the official journal of the International Society of Influenza and Other Respiratory Virus Diseases - an independent scientific professional society - dedicated to promoting the prevention, detection, treatment, and control of influenza and other respiratory virus diseases. Influenza and Other Respiratory Viruses is an Open Access journal. Copyright on any research article published by Influenza and Other Respiratory Viruses is retained by the author(s). Authors grant Wiley a license to publish the article and identify itself as the original publisher. Authors also grant any third party the right to use the article freely as long as its integrity is maintained and its original authors, citation details and publisher are identified.
期刊最新文献
Effectiveness of Original Monovalent and Bivalent COVID-19 Vaccines Against COVID-19-Associated Hospitalization and Severe In-Hospital Outcomes Among Adults in the United States, September 2022–August 2023 Expansion of Laboratory Capacity in the Eastern Mediterranean Region During the COVID-19 Pandemic: Lessons Learned and Future Strategies for Sustainability Inno4Vac Workshop Report Part 1: Controlled Human Influenza Virus Infection Model (CHIVIM) Strain Selection and Immune Assays for CHIVIM Studies, November 2021, MHRA, UK Real-World Assessment of Economic and Clinical Outcomes in Thai Patients With Respiratory Syncytial Virus Infection Across Age Groups: A Retrospective Cohort Analysis Respiratory Diagnoses Year-Round: Unraveling the Multifaceted Pediatric Infection Cycles
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1